Eli L Diamond1, Holly G Prigerson1, Denise C Correa1, Anne Reiner1, Katherine Panageas1, Maria Kryza-Lacombe1, Justin Buthorn1, Elizabeth C Neil1, Alex M Miller1, Lisa M DeAngelis1, Allison J Applebaum1. 1. Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; Center for Research on End of Life Care, Weill Cornell Medical College, New York, New York; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York; San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, San Diego, California; Department of Neurology, University of Minnesota, Minneapolis, Minnesota; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.
Abstract
BACKGROUND: Malignant glioma (MG) is a devastating neuro-oncologic disease with almost invariably poor prognosis. Prognostic awareness (PA) is the awareness of incurable disease and shortened life expectancy (LE). Accurate PA is associated with favorable psychological outcomes at the end of life (EoL) for patients with cancer; however, little is known about PA or prognostic communication in MG. Moreover, research has yet to evaluate the impact of cognitive impairment on PA and preferred forms of communication. METHODS: Fifty MG patients and 32 paired caregivers were evaluated in this exploratory study with a semi-structured PA assessment aimed to measure their awareness of MG incurability and LE. Full PA was defined as awareness of MG incurability and accurate estimate of LE. The assessment included a survey about preferences for prognostic communication (items from the Prognosis and Treatment Perceptions Questionnaire), neurocognitive assessment (Hopkins Verbal Learning Test-Revised, Trail Making Test Parts A and B, and the Controlled Oral Word Association Test), and measurements of mood (Hospital Anxiety and Depression Scale) and quality of life (Functional Assessment of Cancer Therapy-Brain [FACT-Br]). RESULTS: Twenty (40%) patients and 22 (69%) caregivers had full PA. Thirty (60%) patients and 23 (72%) caregivers reported that prognostic information was extremely or very important, and 21 (42%) patients and 16 (50%) caregivers desired more prognostic information. Patients with memory impairment more frequently believed that prognostic information was important (P = 0.04, P = 0.03) and desired more information (P = 0.05, P = 0.003) as compared with those without impairment. CONCLUSIONS: Most MG patients were unaware of their LE. Memory impairment may influence preferences for prognostic information.
BACKGROUND: Malignant glioma (MG) is a devastating neuro-oncologic disease with almost invariably poor prognosis. Prognostic awareness (PA) is the awareness of incurable disease and shortened life expectancy (LE). Accurate PA is associated with favorable psychological outcomes at the end of life (EoL) for patients with cancer; however, little is known about PA or prognostic communication in MG. Moreover, research has yet to evaluate the impact of cognitive impairment on PA and preferred forms of communication. METHODS: Fifty MG patients and 32 paired caregivers were evaluated in this exploratory study with a semi-structured PA assessment aimed to measure their awareness of MG incurability and LE. Full PA was defined as awareness of MG incurability and accurate estimate of LE. The assessment included a survey about preferences for prognostic communication (items from the Prognosis and Treatment Perceptions Questionnaire), neurocognitive assessment (Hopkins Verbal Learning Test-Revised, Trail Making Test Parts A and B, and the Controlled Oral Word Association Test), and measurements of mood (Hospital Anxiety and Depression Scale) and quality of life (Functional Assessment of Cancer Therapy-Brain [FACT-Br]). RESULTS: Twenty (40%) patients and 22 (69%) caregivers had full PA. Thirty (60%) patients and 23 (72%) caregivers reported that prognostic information was extremely or very important, and 21 (42%) patients and 16 (50%) caregivers desired more prognostic information. Patients with memory impairment more frequently believed that prognostic information was important (P = 0.04, P = 0.03) and desired more information (P = 0.05, P = 0.003) as compared with those without impairment. CONCLUSIONS: Most MG patients were unaware of their LE. Memory impairment may influence preferences for prognostic information.
Authors: Areej El-Jawahri; Lara Traeger; Elyse R Park; Joseph A Greer; William F Pirl; Inga T Lennes; Vicki A Jackson; Emily R Gallagher; Jennifer S Temel Journal: Cancer Date: 2013-10-10 Impact factor: 6.860
Authors: Alaka Ray; Susan D Block; Robert J Friedlander; Baohui Zhang; Paul K Maciejewski; Holly G Prigerson Journal: J Palliat Med Date: 2006-12 Impact factor: 2.947
Authors: Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag Journal: N Engl J Med Date: 2012-10-25 Impact factor: 91.245
Authors: Wendy G Lichtenthal; Matthew Nilsson; Baohui Zhang; Elizabeth D Trice; David W Kissane; William Breitbart; Holly G Prigerson Journal: Psychooncology Date: 2009-01 Impact factor: 3.894
Authors: José L Díaz; Pilar Barreto; José M Gallego; Javier Barbero; Ramón Bayés; Juan A Barcia Journal: Acta Neurochir (Wien) Date: 2009-02-18 Impact factor: 2.216
Authors: Akanksha Sharma; Briant Fruth; Celina Barrera; Hannah N Farfour; Maciej M Mrugala; Mark K Edwin; Jeff A Sloan; Alyx B Porter Journal: J Neurooncol Date: 2021-01-23 Impact factor: 4.130
Authors: A J Applebaum; K Buda; M Kryza-Lacombe; J J Buthorn; R Walker; K M Shaffer; T A D'Agostino; E L Diamond Journal: Psychooncology Date: 2017-12-19 Impact factor: 3.894
Authors: Bo Hu; Xiaomeng Yin; Chunyan Du; Hui Zhu; Zhanjun Gao; Xiuli Zhu; Jizhe Wang Journal: Support Care Cancer Date: 2021-08-28 Impact factor: 3.359
Authors: Helle Sorensen von Essen; Frantz Rom Poulsen; Rikke Hedegaard Dahlrot; Karin Piil; Karina Dahl Steffensen Journal: Int J Environ Res Public Health Date: 2022-06-16 Impact factor: 4.614
Authors: Ugur Sener; Elizabeth C Neil; Amy Scharf; Alan C Carver; Justin B Buthorn; Dana Bossert; Allison M Sigler; Louis P Voigt; Eli L Diamond Journal: Neurooncol Pract Date: 2021-06-19
Authors: Laura P Gelfman; Rebecca L Sudore; Harriet Mather; Karen McKendrick; Mathew D Hutchinson; Rachel J Lampert; Hannah I Lipman; Daniel D Matlock; Keith M Swetz; Sean P Pinney; R Sean Morrison; Nathan E Goldstein Journal: Circ Heart Fail Date: 2020-09-02 Impact factor: 8.790
Authors: Deborah A Forst; Kit Quain; Sophia L Landay; Maya Anand; Emilia Kaslow-Zieve; Michelle M Mesa; Jamie M Jacobs; Jorg Dietrich; Michael W Parsons; Nora Horick; Joseph A Greer; Tracy T Batchelor; Vicki A Jackson; Areej El-Jawahri; Jennifer S Temel Journal: Neurooncol Pract Date: 2020-04-17